246 related articles for article (PubMed ID: 8160823)
1. Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma.
Carr ME; Zekert SL
Am J Physiol; 1994 Mar; 266(3 Pt 2):H1195-201. PubMed ID: 8160823
[TBL] [Abstract][Full Text] [Related]
2. Fibrin structure and concentration alter clot elastic modulus but do not alter platelet mediated force development.
Carr ME; Carr SL
Blood Coagul Fibrinolysis; 1995 Feb; 6(1):79-86. PubMed ID: 7795157
[TBL] [Abstract][Full Text] [Related]
3. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots.
Carr ME; Carr SL; Merten SR
Haemostasis; 1995; 25(4):172-81. PubMed ID: 7557656
[TBL] [Abstract][Full Text] [Related]
4. Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma.
Carr ME; Dent RM; Carr SL
J Lab Clin Med; 1996 Jul; 128(1):83-8. PubMed ID: 8759939
[TBL] [Abstract][Full Text] [Related]
5. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus.
Carr ME; Carr SL; Hantgan RR; Braaten J
Thromb Haemost; 1995 Mar; 73(3):499-505. PubMed ID: 7667835
[TBL] [Abstract][Full Text] [Related]
6. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
De Clerck F; Borgers M; de Gaetano G; Vermylen J
Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
[TBL] [Abstract][Full Text] [Related]
7. Measurement of platelet-mediated force development during plasma clot formation.
Carr ME; Zekert SL
Am J Med Sci; 1991 Jul; 302(1):13-8. PubMed ID: 2063881
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
9. Abnormal fibrin ultrastructure, polymerization, and clot retraction in multiple myeloma.
Lackner H; Hunt V; Zucker MB; Pearson J
Br J Haematol; 1970 Jun; 18(6):625-36. PubMed ID: 5428623
[No Abstract] [Full Text] [Related]
10. Interplay of Platelet Contractility and Elasticity of Fibrin/Erythrocytes in Blood Clot Retraction.
Tutwiler V; Wang H; Litvinov RI; Weisel JW; Shenoy VB
Biophys J; 2017 Feb; 112(4):714-723. PubMed ID: 28256231
[TBL] [Abstract][Full Text] [Related]
11. Gamma globulin inhibition of fibrin clot formation.
Davey FR; Gordon GB; Boral LI; Gottlieb AJ
Ann Clin Lab Sci; 1976; 6(1):72-7. PubMed ID: 1247286
[TBL] [Abstract][Full Text] [Related]
12. Clot retraction facilitates clot lysis.
Carroll RC; Gerrard JM; Gilliam JM
Blood; 1981 Jan; 57(1):44-8. PubMed ID: 7448414
[TBL] [Abstract][Full Text] [Related]
13. A phenomenologic description of clot lysis in dilute human plasma correlating structure and function of platelets.
Gilliam JM; Berkus V; Taylor FB
Am J Pathol; 1979 Jul; 96(1):35-50. PubMed ID: 464023
[TBL] [Abstract][Full Text] [Related]
14. Asymmetrical Forces Dictate the Distribution and Morphology of Platelets in Blood Clots.
Kovalenko TA; Giraud MN; Eckly A; Ribba AS; Proamer F; Fraboulet S; Podoplelova NA; Valentin J; Panteleev MA; Gonelle-Gispert C; Cook S; Lafanechère L; Sveshnikova AN; Sadoul K
Cells; 2021 Mar; 10(3):. PubMed ID: 33800866
[TBL] [Abstract][Full Text] [Related]
15. Examining platelet-fibrin interactions during traumatic shock in a swine model using platelet contractile force and clot elastic modulus.
White NJ; Martin EJ; Brophy DF; Ward KR
Blood Coagul Fibrinolysis; 2011 Jul; 22(5):379-87. PubMed ID: 21537163
[TBL] [Abstract][Full Text] [Related]
16. At high heparin concentrations, protamine concentrations which reverse heparin anticoagulant effects are insufficient to reverse heparin anti-platelet effects.
Carr ME; Carr SL
Thromb Res; 1994 Sep; 75(6):617-30. PubMed ID: 7831681
[TBL] [Abstract][Full Text] [Related]
17. Delayed, reduced or inhibited thrombin production reduces platelet contractile force and results in weaker clot formation.
Carr ME; Martin EJ; Carr SL
Blood Coagul Fibrinolysis; 2002 Apr; 13(3):193-7. PubMed ID: 11943932
[TBL] [Abstract][Full Text] [Related]
18. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
Taylor FB; Müller-Eberhard HJ
J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
[TBL] [Abstract][Full Text] [Related]
19. Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
Undas A; Zubkiewicz-Usnarska L; Helbig G; Woszczyk D; Kozińska J; Dmoszyńska A; Podolak-Dawidziak M; Kuliczkowski K
Eur J Clin Invest; 2014 Jun; 44(6):557-66. PubMed ID: 24738991
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of platelet function and clot structure in patients with severe coronary artery disease.
Greilich PE; Carr ME; Zekert SL; Dent RM
Am J Med Sci; 1994 Jan; 307(1):15-20. PubMed ID: 8291501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
